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Abstract
Background: The generation of diverse neuronal types and subtypes from multipotent progenitors during
development is crucial for assembling functional neural circuits in the adult central nervous system. It is well known
that the Notch signalling pathway through the inhibition of proneural genes is a key regulator of neurogenesis in
the vertebrate central nervous system. However, the role of Notch during hypothalamus formation along with its
downstream effectors remains poorly defined.
Results: Here, we have transiently blocked Notch activity in chick embryos and used global gene expression
analysis to provide evidence that Notch signalling modulates the generation of neurons in the early developing
hypothalamus by lateral inhibition. Most importantly, we have taken advantage of this model to identify novel
targets of Notch signalling, such as Tagln3 and Chga, which were expressed in hypothalamic neuronal nuclei.
Conclusions: These data give essential advances into the early generation of neurons in the hypothalamus. We
demonstrate that inhibition of Notch signalling during early development of the hypothalamus enhances
expression of several new markers. These genes must be considered as important new targets of the
Notch/proneural network.
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Background
The hypothalamus influences a broad spectrum of physio-
logical functions, including autonomic nervous system,
reproduction and behaviour. Despite its physiological
importance, we are only beginning to understand the
molecular mechanisms underlying neural differentiation
within this brain region. In the developing hypothal-
amus, progenitor domains were characterized by com-
plex patterns of transcription factor gene expression,
and an important yet unresolved question concerns the
molecular determinants of the neurons produced in each
progenitor domain [1,2].
The hypothalamus develops from the ventral region of
the diencephalon and pattern formation depends on the
activities of major protein signalling pathways, such as
Sonic hedgehog (Shh) and bone morphogenic protein
(BMP) [3]. They are involved in patterning, regional
identity and cell fate determination. Proper development of
the hypothalamic axis then requires signals, which lead to
numerous types of neurons and glia. The temporal control
of the transition from cell proliferation to cell differenti-
ation in the nervous system is believed to involve many
antagonist factors and a proper balance of their actions
is essential for neurogenesis to take place [2,4].
It has been well described that Notch signalling is an
evolutionary conserved mechanism that plays an essen-
tial role in maintaining neural progenitor identity and
suppressing neuronal differentiation [5,6]. The trans-
membrane Notch receptor is activated upon binding to
membrane-bound DELTA or SERRATE ligands present
in adjacent cells. Upon activation of Notch signalling,
the Notch intracellular domain (NICD) is released and
forms a complex with the DNA-binding transcription
factor RBPJ. This complex induces the transcription of
repressor-type basic helix-loop-helix (bHLH) Hes and
Hey genes by binding to their promoters [7,8]. Gain of
function studies have revealed that constitutive Notch
signalling leads to cells remaining as progenitors [9,10],
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whereas loss of NOTCH1 results in the premature dif-
ferentiation of neurons at the expense of undifferenti-
ated cells in the cerebellum [11]. Similarly, Hes1 and
Hes3 double null mice show premature neuron forma-
tion in the mesencephalon and rhombencephalon [12].
Numerous studies have shown that this premature dif-
ferentiation of neurons occurs through transient and se-
quential upregulation of proneural bHLH transcription
factor genes [13-16]. From these studies and numerous
others it has been proposed that to maintain neural
progenitor cells a regulatory loop takes place between
neighbouring cells. This loop involves the upregulation
of Delta-ligand expression by proneural genes and down-
regulation of proneural gene expression by the Notch
signalling pathway through the repressor Hes/Hey genes.
This process is called lateral inhibition [13,17]. Thus,
in the absence of Hes and Hey bHLH repressors, pro-
neural genes such as Ascl1 or NeuroG are significantly
upregulated, and induce expression of a wide spectrum
of neuron-specific genes leading to premature formation
of early-born neurons [18].
Recently, Notch signalling has been strongly implicated
in the differentiation of the mouse hypothalamic arcuate
neurons (Arc) through a loss of function study in the
mouse [16]. This study shows that Notch signalling affects
maintenance of the hypothalamic neuronal progenitor pool
by repressing the proneural gene, Ascl1. However, little is
known about the molecular targets of this Notch/proneural
network during this process.
In order to address the extent to which Notch signal-
ling is required for functional neuronal development we
have taken advantage of its function in the developing
hypothalamus to characterize new target genes. A chem-
ical approach was used to inactivate Notch signalling in
the chick embryo in a specific time-window correspond-
ing to the early steps of hypothalamic neurogenesis.
Microarray analysis has allowed us to describe new
critical neuronal precursor-specific markers that may
be expressed under the control of the Notch/proneural
network.
Results
Expression of Notch components during hypothalamus
development
To identify the exact time point when the Notch path-
way may be required during hypothalamus develop-
ment, we examined the temporal expression of several
Notch components in the developing chick brain be-
tween Hamburger and Hamilton (HH)8 and HH16
(Figure 1 and data not shown).
We observed that expression of Dll1, Hes5 and Hey1
were first detected in and around the ventral midline of
the diencephalon just before HH11 with only a few marked
cells labelled (Figure 1). At HH11, Dll1 expression was
found from the telencephalon to the rostral region of the
diencephalon in scattered cells (Figure 1A). At this stage,
Hes5 was similarly expressed in the rostral region of the
head except at the level of the most anteromedial part of
the telencephalon where its transcripts were not found
(Figure 1E). In contrast, Hey1 expression was restricted
to the rostroventral diencephalon between the two de-
veloping optic vesicles (Figure 1I). Importantly, ventral
views of HH11 dissected neural tube revealed the ven-
tral neurectodermal surface with similar expression
patterns in a crescent-shaped area for Dll1, Hes5 and Hey1
centred around the midline between the optic vesicles
(boxes in Figure 1A,E,I).
As development proceeds, the hypothalamus primor-
dium was morphologically evident from approximately
HH13. At this stage, double in situ hybridization with
Nkx2.1, a general early marker of the hypothalamic plate
[19], revealed an overlapping expression with Dll1, Hes5
and Hey1 that was restricted to the rostral region of the
hypothalamus with rostral expression caudal to the
prospective chiasmatic area (Figure 1C,G,K, asterisk).
At this stage, Dll1 displayed a fine salt-and-pepper-like
pattern (Figure 1C, arrowhead). From HH13, Nkx2.1 had
just started to be expressed separately in the preoptic area
of the basal telencephalon. Dll1 was also expressed in the
preoptic area but not Hes5 and Hey1. Dll1 and Hes5
expression were also found overlapping with Nkx2.1 in
the lateral domain of the hypothalamic region.
The rostral hypothalamus gives rise to the nucleus of
the tract of the postoptic commissure (nTPOC) at HH13
[20] as shown with the HuC/D-positive cells (Figure 2A).
The members of the Notch signalling pathway that were
expressed within the chick diencephalon from HH11
(Figure 1) mapped to the rostral end of the hypothalamus
primordium corresponding to the nTPOC. The specific
colocalisation of Notch components with the nTPOC at
this stage underlines a strong contribution of this pathway
during differentiation of hypothalamic neurons.
Setting up an experimental strategy to identify Notch
response genes in the early developing hypothalamus
To identify Notch response genes we used a chemical
inhibition strategy combined with a global measure of
transcript levels using chicken microarrays. The γ-secretase
inhibitor N-[3.5-difluorophenacetyl-L-alanyl)]-S-phenylglycine
t-butyl ester (DAPT) provides a powerful tool to in-
hibit cell differentiation processes regulated by Notch
[14]. This treatment caused a rapid downregulation of
Hes5 expression after only 3 hours of DAPT-treatment
(Figure 1H).
Based on our previous observations, showing that Notch
components were first detected between HH10 and HH11
in the hypothalamus primordium, the genetic response to
an inhibition of the Notch pathway was analysed from
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Figure 2 Immunostaining for HuC/D in the rostral hypothalamus of DMSO and DAPT-treated chick embryos (n = 6). (A,B) High
magnification of hemisected, flatmounted preparations of the rostral hypothalamus at Hamburger and Hamilton (HH)13. The nucleus of the tract
of the postoptic commissure neurons (nTPOC) was characterized by the expression of the Hu class of RNA-binding proteins that marks
post-mitotic neurons. While the neurons were scattered in the DMSO control (A), after DAPT treatment the nTPOC population becomes denser
(B). DMSO; DAPT, N-[3.5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester.
Figure 1 Regionalized expression of the components of the Notch pathway in the hypothalamus. Expression of Dll1, Hes5 and Hey1 at
Hamburger and Hamilton (HH)11 and HH13 as indicated. All genes were detected initially as a crescent region between the two optic vesicles
(boxes in A,E,I). (B,C,F,G,J,K) Double expression of Dll1, Hey1 or Hes5 (blue) with Nkx2.1 (red) at HH13, showing that the expression of all the
genes occupies the rostral region of the hypothalamus. (C,G,K) Hemisected, flatmounted preparation of the ventral diencephalon of the
corresponding embryos in B,F,J, respectively, with the optic vesicles removed and viewed from the ventral side. Arrowheads indicate scattered
cell expression. Asterisk indicates rostral expression caudal to the prospective chiasmatic area. (D,L) HH10 chick embryos were treated with
N-[3.5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT) or (DMSO) for 16 hours. (H) Embryos were treated for only 3 hours from
HH12. There was downregulation of Hes5 (H) and Hey1 (L) expression after DAPT treatment, whereas Dll1 was upregulated (D). AH, anterior (rostral)
hypothalamus; D, diencephalon; H, hypothalamus; pH, hypothalamus primordium; POA, preoptic area; T, telencephalon, V, optic vesicle.
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HH10 to HH13, corresponding to an overnight culture
(16 hours). HH10 embryos were dissected and transferred
into roller tubes, in which they were cultured for 16 hours
either in Dimethyl sulfoxide (DMSO) or 40 μM DAPT-
supplemented medium. With such conditions, the size of
the embryos was similar between DAPT-treated and con-
trol embryos with no obvious morphological defects. In all
DAPT-treated embryos analysed, the expression of Hes5
(n = 20) and Hey1 (n = 15) was dramatically reduced or
abolished in the neural tube and forebrain, including the
ventral diencephalon (Figure 1L). It has been well
established that downregulation of Hes5 de-represses
the expression of Dll1 [18]. Accordingly, the DAPT
treated embryos (n = 15) exhibit increased expression of
Dll1 after 16 hours of treatment (Figure 1D). Furthermore,
Notch inhibition during this period was associated with
an increase in the number of neurons and a loss of the
scattered neurons in the rostral hypothalamus (Figure 2).
Therefore, a treatment starting at HH10 for 16 hours
appeared to be appropriate to identify direct or indirect
downstream targets of Notch signalling during the first
step of hypothalamic neurogenesis.
Identification of Notch response genes in the
developing forebrain
HH10 embryos were treated with DAPT and harvested
after 16 hours culture, at approximately HH13, for a
comparative microarray analysis. To restrict our find-
ings to genes that were controlled by Notch in the
prosencephalon-forming region, we dissected a domain
that was situated rostral to the mesencephalic region
containing the hypothalamic primordium. This domain
was chosen because it was morphologically well delimited
at the stage of dissection. For each experiment, five prosen-
cephalons from the same culture were dissected and pooled
to obtain total RNA. Four different sets of experiments
were collected and tested by microarray, using chick gen-
ome 4x44k DNA-microarray (Agilent, Massy, France; [21]).
The DMSO and DAPT-treated embryos were directly
compared by Genespring GX software version 12.0 Agilent.
We opted for a fold-change (FC) of 1.3 cut-off and identi-
fied 789 downregulated and 769 upregulated genes in the
DAPT-treated forebrain.
It was noted that members of the Notch signalling
pathway were significantly enriched in Gene Ontology
(GO) term analysis. As expected, many Notch tran-
scriptional targets and/or Notch pathway components
have their expression consistently modified in our data
(Table 1). The direct Notch target gene Hes5 was highly
downregulated (FC −56.83); also downregulated was Hey1
(FC −2.89). As expected, Dll1 was upregulated (FC 2.26)
[22]. Additionally, we identified changes in expression
levels of other components of the Notch pathway: Jag1
(FC −1.58) [23], Numb (FC –1.49) [24], Lfng (FC −1.45),
Notch1 (FC −1.31) and Nrarp (FC −2.01) [25] that were
downregulated (Table 1). Other components were upregu-
lated, which have not been previously described as Notch
targets: Aph1A (FC 1.34) and Mfng (FC 3.14) [26].
Enrichment for the GO term Nervous System Development
that included 271 genes was observed. Several proneural
genes normally repressed by the Notch pathway were
upregulated [17]. These included Ascl1 (FC 1.67), NeuroG1
(FC 8.85) and NeuroG2 (FC 1.57). Thus, DAPT treatment
caused the expected response amongst Notch signalling
pathway components, including Notch effector genes and
proneural bHLH transcription factors. This demonstrated
the validity of the microarray approach for identifying new
target genes of the Notch signalling pathway.
In situ hybridization validation of upregulated genes
To identify new molecular markers regulated directly or
indirectly by Notch signalling we focused our efforts
on the upregulated genes. We obtained efficient RNA
probes for 23 upregulated markers from the enriched
GO term Nervous system development (Table 1). These
genes represented diverse functional classes and were
either uncharacterized or only partially described during
hypothalamus development. Some of these genes were
already known hypothalamic markers (such as Robo2
and Slit1) or Notch targets in other tissues (such as
Nhlh1 and Stmn2) [1,2,27]. Most of the selected genes
consisted of transcription factors, binding proteins or
specific neural progenitor genes.
We systematically compared the expression of these genes
in control (DMSO) to DAPT-treated embryos in the same
conditions as the microarray (Figure 3). Remarkably, among
the upregulated genes tested, eight displayed a prominent
tightly restricted expression in the rostral hypothalamus in
DAPT-treated embryos (Figure 3). Interestingly, for some
of these genes, this upregulation was not just restricted to
the hypothalamus but was also within other domains
of expression such as the roof of the mesencephalon,
the olfactory epithelium or the forming ganglions.
After DAPT-treatment, Ascl1 expression (n = 10) was
upregulated in all tissues of the head that normally
expressed this gene (Figure 3A,B). This included the
neuroectoderm of the ventral diencephalon corresponding
to the developing hypothalamus as shown with the dis-
sected neural tube (Figure 3B). Expression of Nhlh1
has been shown to be regulated by Ascl1 and previously
described in the olfactory epithelium, cranial ganglia
and dorsal root ganglia [13] but not in the developing
hypothalamus. Here, scattered Nhlh1-positive cells were
found throughout the ventral midline between the two
optic vesicles of HH13 control embryos (Figure 3E). In
contrast, the density of Nhlh1-positive cells appeared
higher in DAPT embryos (n = 12) at the level of the ventral
diencephalon (Figure 3D,E). Furthermore, Nhlh1 was
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aberrantly expressed in the olfactory placodes and the
roof of the mesencephalon at this stage, whereas only a
few scattered cells expressed this gene in the control
embryos. Importantly, Ascl1 and Nhlh1 displayed the
same profile of upregulation in DAPT-treated embryos.
Stmn2 (previously called SCG10) codes for a cytoskeletal
protein and is an early marker of neuronal phenotype [28].
Here, in DAPT embryos (n = 10) this gene was strongly up-
regulated in the developing hypothalamus, and its scattered
distribution was also lost (Figure 3G,H). This upregulation
has been classically associated with upregulation of Ascl1
and Nhlh1 [13]. Altogether this signifies a change in the
Table 1 Example of expression values for genes selected with an absolute fold change ≥1.3 after Gene Ontology enrichment
Gene symbol Accession number Description Fold change value
Notch signalling pathway components
Hes5 NM_001012695 Hairy and enhancer of split 5 (Drosophila) −56.83
Hey1 XM_425926 Hairy/enhancer-of-split related with YRPW motif 1 −2.89
Nrarp XM_428951 Notch-regulated ankyrin repeat protein −2.02
Jag1 XM_415035 Jagged 1 −1.58
Numb NM_204835 Numb homolog (Drosophila) −1.49
Lfng NM_204948 LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase −1.46
Notch1 XM_415420 Notch 1 −1.31
Notch2 XM_001233595 Notch 2 −1.30
Aph1a XM_001233301 Anterior pharynx defective 1 homolog A (C. elegans) 1.34
Dll1 NM_204973 Delta-like 1 (Drosophila) 2.26
Mfng XM_416278 MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase 3.15
Nervous system development Gene Onotology term (upregulated genes)
Neurog1 NM_204883 Neurogenin 1 8.85
Nhlh2 AF123885 Nescient helix loop helix 2 4.18
Nefm NM_001101730 Neurofilament, medium polypeptide 4.05
Tagln3 XM_416634 Transgelin 3 3.69
Nhlh1 NM_204121 Nescient helix loop helix 1 3.47
Stmn2 NM_205181 Stathmin-like 2 2.49
Nr5a1 NM_205077 Nuclear receptor subfamily 5, group A, member 1 1.87
Nrg1 NM_204117 Neuregulin 1 1.77
Chga CR523039 Chromogranin A (parathyroid secretory protein 1) 1.74
Sim1 U40058 Single-minded homolog 1 (Drosophila) 1.74
Bsx NM_204512 Brain-specific homeobox 1.68
Ascl1 NM_204412 Achaete-scute complex homolog 1 (Drosophila) 1.67
Nr5a2 NM_205078 Nuclear receptor subfamily 5, group A, member 2 1.59
Gap43 XM_425527 Growth associated protein 43 1.57
Neurog2 NM_204796 Neurogenin 2 1.57
Sox14 NM_204761 SRY (sex determining region Y)-box 14 1.51
Robo2 XM_416674 Roundabout, axon guidance receptor, homolog 2 (Drosophila) 1.46
Cntn2 NM_001004395 Contactin 2 (axonal) 1.39
Slit1 XM_421715 Slit homolog 1 (Drosophila) 1.37
Hes6 BX935736 Hairy and enhancer of split 6 (Drosophila) 1.36
Bdnf NM_001031616 Brain-derived neurotrophic factor 1.34
Foxn4 NM_001083359 Forkhead box N4 1.31
Chrdl1 NM_204171 Chordin-like 1 1.30
HH10 embryos were treated with N-[3.5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT) or Dimethyl sulfoxide (DMSO) for 16 hours, and global
change in gene expression of the forebrain was compared by microarray analysis. Two Gene Ontology enriched terms have been selected: Notch signalling
pathway and Nervous system development. This Gene Ontology term contains 271 enriched genes; 135 were upregulated. Here we have listed the 23 genes for
which we have obtained RNA probes. The title and description for each gene are given as well as the accession number and the fold change.
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Figure 3 (See legend on next page.)
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number and density of neurons and a precocious neuro-
genesis in and around the ventral midline. This was also
confirmed using the HuC/D antibody on DAPT-treated
embryos (Figure 2B). These observed effects fit with
the expected role of Notch in regulating the number of
neuronal precursors by lateral inhibition [17,29].
Among the other upregulated genes in the ventral
diencephalon, two have been previously described in
the mouse hypothalamus: Robo2 and Slit1 [27]. In the
control embryos, Slit1 expression was just emerging,
whereas after DAPT treatment (n = 13), Slit1 was up-
regulated in the ventral midline area (Figure 3J,K). At
the same stage, Robo2 expression was not detectable
in the ventral midline of the control embryos, whereas
DAPT-treated embryos (n = 14) expressed this gene
(Figure 3M,N). Robo2 was also upregulated in the forming
ganglions and olfactory placodes when Notch signalling
was inhibited (Figure 3M). Notably, all these tissues
normally displayed Notch activity [29].
Most interestingly, Tagln3, Chga and Chrdl1 were three
genes that were not well documented. Their expressions
have never been described in the developing hypothalamus
or dependent of Notch signalling.
TAGLN3, a microtubule-associated protein, has been
described as a neuron-specific protein in the developing
neural tube [30]. In the control brain (n = 17), Tagln3 was
strongly expressed in the ventral diencephalon and showed
a scattered mRNA distribution, which was lost after DAPT
treatment (Figure 3P,Q). Tagln3 was upregulated in all the
tissues normally expressing this gene, which included
the olfactory placodes, the ventral diencephalon, the
mesencephalic roof, the ganglions and the neural tube
(Figure 3R). Chga has been shown to be a member of the
granin family of neuroendocrine secretory proteins, located
in secretory vesicles of neurons and endocrine cells [31];
however, little has been discussed about its role during the
early embryonic stages. When treated with DAPT, the level
of Chga expression was increased in all the tissues normally
expressing this gene at HH13 (n = 19), which includes
the ventral diencephalon and the olfactory placodes as
for Tagln3 (Figure 3S). Robo2 and Chga were expressed
in the hypothalamus at HH13 but only when Notch ac-
tivity was inhibited (HH13 in Figure 3N,T). Neverthe-
less, when Notch activity was normal these genes were
expressed in the ventral hypothalamus from HH15
(HH15 in Figure 3O,U).
Notably, at HH15, Tagln3 and Chga were similarly
expressed in and around the ventral midline of the di-
encephalon, the forming ganglions and dorsal mesen-
cephalon (Figure 3R,U). Interestingly, a few scattered
cells expressed these genes in the olfactory epithelium
(Figure 3R,U, arrowheads) suggesting a function for
these new markers during olfactory sensory neurons
differentiation.
Remarkably, Chrdl1, a BMP antagonist [32], had its
expression restricted to the developing hypothalamus
at HH13 and in DAPT treated embryos (n = 20). Chrdl1 ex-
pression was clearly upregulated in this area (Figure 3V,W).
At HH15, Chrdl1 kept its restricted expression in the
rostroventral hypothalamus and expression was not
detected in other tissues of HH15 embryos (Figure 3X
and data not shown).
All eight genes were visibly expressed ventrally at the
level of the midline in the area localized between the two
optic vesicles (Figure 3) corresponding to the expression
domain of the Notch components previously described in
Figure 1 and the nTPOC (Figure 2). In order to confirm
that these expression domains were restricted to the future
rostral hypothalamus, in addition to Nkx2.1, Shh was also
used as a marker. At HH14, Shh was expressed exclusively
along the ventral midline of the neural tube but, contrary
to Nkx2.1, displayed a dynamic distribution at the level
of the hypothalamus subregions [33]. As shown by the red
staining in Figure 4, the future hypothalamus was arranged
rostrocaudally into the anterior (rostral), tuberal and
mammillary region (Figure 4). To compare precisely the
expression profiles of Shh and Hey1, embryos were double
labelled at HH14. Expression of Hey1 was confined to the
Shh-positive cells of the anterior hypothalamus in the same
region that the proneural gene Ascl1 and Tagln3 were
expressed (Figure 4). At this stage, Hey1, Ascl1 and Tagln3
displayed a salt-and-pepper-like pattern in this area.
Identification of a transcriptional program regulated by
Hes5/Hey1, Ascl1 and Nhlh1
It has been established that a conserved Ascl1/Dll1/
Hes/Hey/Nhlh1 molecular circuitry operates within the
progenitor pool to coordinate neurogenesis [34]. In order
(See figure on previous page.)
Figure 3 Regionalized expression of upregulated genes in the hypothalamus in DAPT-treated chick embryos. Whole embryo in situ
hybridization was performed with Ascl1 (A-C), Nhlh1 (D-F), Stmn2 (G-I), Slit1 (J-L), Robo2 (M-O), Tagln3 (P-R), Chga (S-U) and Chrdl1 (V-X)
riboprobes on control and DAPT-treated embryos after 16 hours ex-ovo culture and on Hamburger and Hamilton (HH)15 embryos as
indicated on the figure. In B, E, H, K, N, Q, T and W, mesenchymal cells and surface ectoderm were removed to obtain dissected neural
tubes (ventral view) from the embryo described on the left side. Small arrows highlight specific expression of all these probes in the rostral
hypothalamus. Arrowheads point to the expression in the olfactory epithelium. g, ganglia; m, roof of the mesencephalon; o, optic vesicles.
DAPT, N-[3.5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester.
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to test if the new candidate genes characterized in this
study could have their expression directly regulated by
this network, an in silico approach was used to determine
DNA-binding signatures for ASCL1, HES5, HEY1 and
NHLH1 and to detect the presence or the absence of these
sites at the level of the promoter of the genes implicated
in this circuitry.
By using the MatInspector (Genomatix, Munich, Germany)
and Evolutionary Conserved Region (NIH, USA) browser
software, the available proximal promoter sequences of se-
lected genes were screened for binding sites in numerous
organisms in order to find some cross-species genomic
conservation. These promoters were defined as sequences
0.5 Mb before and 0.1 Mb after the transcription start site
(+1). Despite a poor degree of nucleotide homology
between mouse and chick proximal promoter regions
of Hes5 and Dll1, we found a conserved sequence of seven
nucleotides (5’-CACCTGC-3’ - MHAM) corresponding
to an antagonist-binding site for ASCL1/HEY (Figure 4).
Importantly, this motif allowed us to give a better strin-
gency condition to the in silico study compared to degener-
ated E-box (5'-CANNTG-3') and N-box (5’-CACNAG-3’)
sequences attributed to ASCL1 or HEY1 alone [13]. Here,
we described this motif at the level of the Chga and Chrdl1
proximal promoters (Figure 5). This ASCL1/HEY motif
was also found at the level of the Mnfg promoter, a
known direct target of ASCL1 [34].
We also observed another conserved sequence of strict
7-mer nucleotides (5’-GCAGCTG-3' - MNAM) previously
described as a direct binding sequence for Ascl1 [35]
that correspond to an antagonist-binding site for ASCL1/
NHLH1. This sequence was found conserved in the prox-
imal promoter region of Robo2 and Tagln3.
It can therefore be proposed that these regulatory
elements, which were selected for enrichment in the
Ascl1/Dll1/Hes/Hey/Nhlh1 molecular circuitry, may
represent signatures to drive expression in some neural
tissues. Obviously the functional relevance of this finding
has yet to be exhaustively explored. This in silico approach
along with literature led us to propose a predictive model
of gene regulation for neurogenesis in the hypothalamus,
but this cannot be excluded as a model for other neuronal
tissues such as the ganglia where neurons also differenti-
ated during early development and expressed these new
target genes (Figure 5).
Discussion
In this report, ex ovo roller culture of chick embryos has
allowed DAPT to be delivered at a specific concentration
and time. We show that pharmacological inhibition of
Notch signalling can phenocopy the experimental results
obtained with other methods, but allows better temporal
control [29]. Treatment with DAPT caused a rapid de-
cline in downstream components of the Notch signalling
pathway (that is, Hes5) that initiates the molecular cas-
cade leading to the upregulation of the proneural bHLH
gene, Ascl1, and the Notch ligand, Dll1. Numerous studies
using genetic models have reported the same effect at the
level of various developing tissues such as the olfactory
epithelium, the roof of the mesencephalon and neural
tube [18,29,36-39]. An example is the phenotype of the
null mutant mice for RBPJ, the essential transcription
factor mediating signalling of all Notch receptors [29].
Hes5 transcripts normally present in the brain and
spinal cord were completely eliminated in RBPJ mutant
embryos, whereas Dll1 and Ascl1 were upregulated along
Figure 4 (A-F) Hamburger and Hamilton (HH)14, dissected chick neural tube. Expression of Notch pathway component, Hey1 (A,B), the
proneural gene Ascl1 (C,D) and a new putative target gene, Tagln3 (E,F) in the hypothalamus compared to Shh expression at HH14. The figure
shows that these three genes were similarly expressed in the rostral region of the hypothalamus (AH). (A,C,E) Lateral views with the rostral
region on the left. (B,D,F) Ventral views of the corresponding embryos A, C, and E. Arrowheads show the patched expression of Hey1, Ascl1 and
Tagln3. AH, anterior (rostral) hypothalamus; D, diencephalon; H, hypothalamus; LH, lateral hypothalamus, MH, mammillary region of the
hypothalamus, T, telencephalon, TH, tuberal region of the hypothalamus.
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with neuronal differentiation markers such as Nhlh1 [29].
In our ex ovo experiments, this premature neuronal differ-
entiation was similarly observed in the neural tube, mes-
encephalon and developing cranial placodes and ganglia.
This study using RBPJ null mice further highlights the
validity of our method.
Surprisingly, an accurate description of Notch activity
during the earliest stages of mouse or chick hypothal-
amus development when the first neurons differentiate
was not reported. However, scarce studies indicate that
Dll1, Notch2 and Hes5 expression was spatially and tem-
porally restricted to the developing mouse diencephalon
from E9.5 (+/− HH11 in chick) [4,40,41]. A temporal as-
sessment of Notch pathway effectors (for example, Hes5)
indicated high and localized expression within the chick
diencephalon in the ventral-most cells as early as HH11.
Based on the hypothalamus markers, Nkx2.1 and Shh
[19,33], we concluded that this Notch-positive region
corresponds to the hypothalamic cells of the prospective
anterior hypothalamus. Because Hes5 was transcribed
in the embryo solely in response to Notch signalling
[8], we thus demonstrate that the first evidence of
Notch activity in the chick hypothalamus starts very
early on during the neuron progenitor expansion [20].
The Hey1 expression domain overlaps with Hes5 in the
presumptive hypothalamus, further suggesting that these
genes may have overlapping functions in this tissue. These
results were supported by a study that has shown that a
reduction in Hes/Hey gene dosage led to an overproduc-
tion of neurons during hair cell formation [42].
In agreement with previous studies conducted in verte-
brate embryos, the salt-and-pepper-like patterns observed
for Dll1, Hes5, Hey1 and Ascl1 in the rostral hypothalamus
suggested that lateral inhibition regulates early production
of hypothalamic neurons [17,43]. During this event, scat-
tered cells expressing Dll1 activate Notch in their neigh-
bouring cells inducing the expression of the transcriptional
repressors of the Hes/Hey family genes. They repress the
expression of proneural bHLH genes that are essential for
specifying neural fate [17]. In this study, by treating chick
embryos with DAPT from HH10, HuC/D-positive cells
were found grouped in a dense cluster of adjacent cells in
DAPT-treated embryos, whereas they remained scattered
in control embryos. Thus, an excessive number of cells dif-
ferentiated into neurons in the ventral hypothalamus in the
absence of Notch activity. This precocious neurogenesis
was the typical “neurogenic” phenotype expected for the
loss of function of Notch if working by lateral inhibition
[9,36]. This was confirmed by the upregulation of Ascl1 and
by the loss of the salt-and-pepper profile of the neuronal
B C
A
Figure 5 Summary of potential regulatory interaction model of gene regulation for neurogenesis in the hypothalamus revealed by in
silico analysis and literature. (A) Schematic of mouse Hes5, Dll1, Robo2, Tagln3, Chga and Chrdl1 promoters showing the position of
evolutionarily conserved binding motifs for HES5 (light green box), ASCL1 (red box), antagonist binding sites ASCL1/HEY1 (MHAM, red and green
box) and ASCL1/NHLH1 (MNAM, red and orange box). Regulatory regions comprise 500 bp before to 100 bp after the transcription start site
(+1, blue arrow). The schematic represents only the motifs that were conserved among several species. (B) Consensus chick and mouse box
sequences from the literature and this study. (C) A model of interaction between the negative regulators HES5 and HEY1 and the positive
regulators ASCL1 and NHLH1 based on the literature and present data. Activations are identified with a red arrow and repressions are identified
with a green barred line. The purple arrow refers to the activation of NOTCH receptor by its ligand DLL1. (Bertrand, 2002; Gohkle, 2008, Castro,
2011, de la Pompa 1997, and present data) [13,29,34,50].
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markers Nhlh1 and Stmn2 in the absence of Notch activity.
Thus, we propose for the first time that a mechanism of
lateral inhibition operates in the rostral hypothalamus of
the vertebrate brain to generate neurons.
This mechanism was most probably mediated by the
proneural gene Ascl1. At E10.5, Ascl1 was the major
bHLH proneural gene expressed at the level of the mouse
basal plate expressing Nkx2.1, whereas other proneural
genes such as Neurog1 and Neurog2 have their expression
restricted to the dorsal brain [40]. In the chick brain,
Neurog1 and Neurog2 expression was not detected during
the early phase of ventral hypothalamus development
(data not shown) whereas Ascl1 expression was restricted
to the rostral domain of Shh. Concordantly, targeted mu-
tagenesis demonstrated an essential role for Ascl1 during
the generation of ventral neuroendocrine neurons as
well as playing a central role in subtype specification of
these neurons [40].
Loss of function through gene mutations provides an
essential tool to confirm whether the Notch pathway
has an early function during hypothalamus neurogen-
esis. However, single null mice for components of Notch
(ligands or receptors) and their mediators (such as Hes1,
Hes5 or Hey1) display defects in restricted areas of the
developing embryo [36,44-46]. While Hes5 mutant mice
do not show any gross abnormalities, in the absence of
both Hes1 and Hes5 genes cell differentiation was severely
accelerated, leading to aberrant neuronal localization [18].
This redundancy between the major genes of the Notch
pathway may explain why a role for Notch during the
earliest stages of hypothalamus formation has never been
strongly attributed to this pathway before. Only recently,
conditional knockout mice lacking RBPJ in the forming
hypothalamus were obtained [16]. However, no investi-
gations at the early stage of hypothalamus development
have been done. Concordantly, these mice showed an
increased proliferation of the Arc neurons at E13.5 that
may contribute to the increased body weight phenotype
observed in the mutants. This abnormality probably
takes place at earlier stages, as the Nkx2.1-Cre that has
been used to drive Notch gene inactivation was active as
early as E10.5 [47].
Other major findings in this paper were the char-
acterization of new components of the differentiation
programme of neural progenitor cells of the hypothalamus
but also of the ganglia and olfactory epithelium. We have
independently verified the results of our microarray screen
using RNA in situ hybridization and demonstrated that
many of these genes were specifically expressed in the
hypothalamus at HH15. The specific expression of
Chrdl1 in the rostral hypothalamus was very fascinat-
ing, as the BMP pathway has been strongly implicated,
coupled with Shh for the early patterning of the hypo-
thalamus and in neuronal maturation [3]. This suggests
that Notch signalling may regulate the activity of BMP
signalling in this area.
We have additionally identified markers of early differ-
entiating neurons such as Nhlh1, markers implicated in
axon outgrowth such as Stmn2 and in axon guidance such
as Robo2 and Slit1. Robo2 and Slit1 were expressed in the
mouse developing hypothalamus from E10.5 and were
required to maintain proper balance between primary
and intermediate neuronal progenitors [27]. This function
was probably conserved in the chick.
Most interestingly, characterization of other unknown
potential neuronal markers such as Tagln3 and Chga in the
developing hypothalamus gave us a high level of confidence
in our approach to discover new molecules regulated by
Notch signalling. TAGLN3 is a microtubule-associated
protein [48] and CHGA is a protein released in the cir-
culation by neurons that interacts with STMN2 in hu-
man neuroendocrine cells [49].
At HH15, the comparison between Tagln3 and Chga
expression revealed a virtually identical expression pattern,
not only in the hypothalamus but also in the olfactory
epithelium and forming ganglions. They were similarly
upregulated in all these tissues when Notch activity was
blocked. These expression patterns restricted to neural
tissue have not been reported before. Therefore, these
genes must be considered as important new molecular
markers for neurogenesis.
Importantly, Tagln3, Chga, Robo2, Slit1 and Chrdl1
expression has been highlighted in this study to be
controlled by the Notch/proneural genes network. This
cascade of genes allows cells to escape lateral inhibition
(neuronal progenitor) to enter the pathway that leads to
terminal neuronal differentiation (Figure 5). It was clear
that coordination between numerous proneural factors
was necessary for the specification of the neuronal sub-
types of the ventral hypothalamus. There are numerous
studies in which Ascl1 has been identified to regulate
other bHLH genes (that is, Neurog3, NeuroD, Nhlh1),
which in turn activates neuron-specific structural genes
such as Stmn2 [4,13]. Interestingly, a genome-wide chip
assay has shown that ASCL1 directly binds Tagln3 pro-
moter [50]. ASCL1 and CHGA have the same overex-
pression profile in small-cell lung cancer [51]. Although
we have no in vitro or in vivo evidence that HES5, HEY1,
ASCL1 and/or NHLH1 directly binds to or regulates
the expression of Chga, Chrdl1 and Robo2 genes, we
have found several well conserved putative HEY1-, and
ASCL1- and NHLH1-binding sequences located within
the 600 bp around their transcription start sites. Certainly,
a more detailed fate map study of these neuronal markers
will be required to better understand how they contribute
to the specification of the hypothalamic sensory territories.
In the meantime, our data have been compared with other
screens and genome wide chip experiments to build a
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model of the regulatory cascade [34,50] that may regulate
neurogenesis at the level of the hypothalamus and possibly
other regions of the developing embryo (Figure 5).
Conclusions
Given the almost universal use of Notch/proneural network
in cell fate renewal and transition, it was necessary to
look for new molecular targets. We uncovered that
Notch signalling modulates the generation of neurons
in the early developing hypothalamus by lateral inhibition.
Most importantly, our global approach allowed us to
characterize several new markers expressed in this tissue
and that may have their expression under the control of
the Notch/proneural genes oscillating regulation. The elu-
cidation of this Notch/proneural transcriptional cascade
including these new genes will be a challenge in the future
since hypothalamic development has considerable import-
ance for human health. Genetic defects in the development
of specific cell subtypes in hypothalamus have already been
reported for congenital obesity [52].
Methods
Roller-tube culture and drug treatments
Isa Brown fertile hen eggs were obtained from the
Amice-Soquet hatchery (Lanrelas, France) and incu-
bated in a humidified 38°C incubator for the desired stages.
Embryos were staged according to Hamburger and
Hamilton [53]. Embryos were collected at HH10 and
cultured as described previously [54]. The γ-secretase
inhibitor DAPT (Sigma, France) was dissolved in
DMSO [55]. Embryos were treated with DMSO or 40 μM
of DAPT in L15 culture medium (supplemented with chick
serum and gentamycin). Animal experimentation protocols
conformed to the European Union guidelines (RL2010/63/
EU). Ethical approval was not required.
mRNA expression profiling on microarray
A whole genome microarray analysis was performed on
total RNA extracted from 5-pooled prosencephalon. Chick
embryonic prosencephalon was dissected after 16 hours
roller culture with DMSO or DAPT. Total RNA was im-
mediately extracted. The RNA quality had been controlled
by 2100 Bioanalyzer (Agilent). Total RNA (50 μg) from
each sample was reverse transcripted and cRNAs were
prepared according to the Agilent recommendations
and following the one-colour protocol to be labelled with
Cy3-CTP. Hybridization was accomplished on the Agilent
4x44K whole chicken genome in situ oligonucleotide
microarray (Agilent) [21]. Image acquisition was performed
using the Agilent Scanner (Biogenouest, Rennes) and sig-
nals were extracted by Agilent Feature Extraction software.
The array files were submitted to the NIH Gene Expression
Omnibus database (accession number GEO: GSE53129).
Data normalization was performed by a per-chip 50th
percentile method by the Genespring Agilent GX12.
GO analysis was performed using Webgestalt online
software (http://bioinfo.vanderbilt.edu/webgestalt/). The
Homo Sapiens Genome was selected as a reference set for
enrichment analysis. Webgestalt used a hypergeometric stat-
istical method and an adjustment of Benjamini-Hochberg
for the Multiple Test with a significance level of 0.05.
Nervous system development enrichment was significant
with adjP = 1.55e-22. Notch signalling pathway enrich-
ments performed on KEGG and Pathways Commons
analysis were significant with respect to: adjP = 6.96e-07
and adjP = 5.80e-06.
Whole-mount in situ hybridization and
immunohistochemistry
After harvesting, embryos were fixed with 4% paraformal-
dehyde in phosphate buffered saline. Whole-mount in situ
hybridization was performed as described [56]. All probes,
except Dll1, were generated by PCR which were subcloned
in pCR®II-TOPO® (Invitrogen, Cergy Pontoise, France) and
used to transcribe the antisense RNA probes. A plasmid
carrying chick Dll1 (NotI-T3; gift of Frank Schubert, UK)
was used. Double in situ hybridization on whole embryos
was done with Digoxigenin and Fluorescein labelled RNA
probes (Roche, Meylan, France). The protocol for im-
munohistochemistry has been described previously [57].
Whole-mount roller culture embryos were stained using
pro-neural antibody, anti-human HuC/D (1:500, 16A11,
Life technologies, Saint-Aubin, France).
Design of transcription factor binding sites and comparative
genomic analysis of promoters in various species
Mouse and chick genomic sequences were downloaded
from the UCSC Genome Browser and Entrez Gene
Databases. Mouse promoters were downloaded from
The Eukaryotic promoter database and compared to
proximal promoters predicted with PromScan Software.
Mouse and chick promoters were annotated with different
specific motifs such as TATA boxes using YAPP Software
(http://www.bioinformatics.org/yapp/cgi-bin/yapp_intro.cgi).
Predictive transcription factor-binding consensus sequences
were obtained using MatInsepctor Position Specific
Scoring Matrix libraries [58]. Relevant binding sites
were analysed using multiple alignments and consensus
sequences were transformed in IUPAC strings. These
strings were reported on selected gene promoters. Finally
a comparative genomic study was performed for binding
sites between mammal and bird when available.
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